NASDAQ : INNV
InnovAge Holding Corp. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 9.24 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.26B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.25B |
| Enterprise Value | 1.20B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 136.45M |
| Shares Outstanding | 136.45M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +1.07% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 13.82% |
| Float | 34.40M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 20.87 |
| PS Ratio | 1.27 |
| Forward PS | 1.17 |
| PB Ratio | 5.31 |
| P/TBV Ratio | 13.88 |
| P/FCF Ratio | 24.88 |
| P/OCF Ratio | 19.38 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.21 |
| EV / EBITDA | 44.57 |
| EV / EBIT | 207.83 |
| EV / FCF | 23.80 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.05 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 2.58 |
| Debt / FCF | 1.73 |
| Interest Coverage | 0.94 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -0.26% |
| Return on Assets (ROA) | 0.67% |
| Return on Invested Capital (ROIC) | -6.92% |
| Return on Capital Employed (ROCE) | 1.63% |
| Weighted Average Cost of Capital (WACC) | 3.57% |
| Revenue Per Employee | $395,883 |
| Profits Per Employee | -$1,015 |
| Employee Count | 2,500 |
| Asset Turnover | 1.83 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 949,000 |
| Effective Tax Rate | 356.77% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +90.66% |
| 50-Day Moving Average | 9.84 |
| 200-Day Moving Average | 9.07 |
| Relative Strength Index (RSI) | 45.72 |
| Average Volume (20 Days) | 573,555 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.15M |
| Short Previous Month | 2.67M |
| Short % of Shares Out | 0.84% |
| Short % of Float | 3.33% |
| Short Ratio (days to cover) | 1.36 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 989.71M |
| Gross Profit | 677.61M |
| Operating Income | 5.77M |
| Pretax Income | 266,000 |
| Net Income | -2.54M |
| EBITDA | 26.91M |
| EBIT | 5.77M |
| Loss Per Share | -$0.02 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 141.33M |
| Total Debt | 86.95M |
| Net Cash | 54.38M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 268.78M |
| Book Value Per Share | 1.73 |
| Working Capital | 10.42M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 64.71M |
| Capital Expenditures | -14.31M |
| Depreciation & Amortization | 21.14M |
| Net Borrowing | -16.41M |
| Free Cash Flow | 50.41M |
| FCF Per Share | $0.37 |
Margins
| Measure | Value |
|---|
| Gross Margin | 68.47% |
| Operating Margin | 0.58% |
| Pretax Margin | 0.03% |
| Profit Margin | -0.26% |
| EBITDA Margin | 2.72% |
| EBIT Margin | 0.58% |
| FCF Margin | 5.09% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | -0.23% |
| Earnings Yield | -0.22% |
| FCF Yield | 4.02% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.00 |
| Price Target Difference | 30.58% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.32 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |